LKFT Stock Summary and Trading Ideas (Lakefront Biotherapeutics - American Depositary Shares | NASDAQ:LKFT)

Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.

Lakefront Biotherapeutics - American Depositary Shares trades on the NASDAQ stock market under the symbol LKFT.

As of October 6, 2026, LKFT stock price declined to $29.27 with 196,723 million shares trading.

LKFT has a beta of 0.14, meaning it tends to be less sensitive to market movements. LKFT has a correlation of 0.00 to the broad based SPY ETF.

LKFT has a market cap of $1.92 billion. This is considered a Small Cap stock.

Last quarter Lakefront Biotherapeutics - American Depositary Shares reported $22 million in Revenue and $.29 earnings per share. This beat revenue expectation by $14 million and exceeded earnings estimates by $13.81.

The top ETF exchange traded funds that LKFT belongs to (by Net Assets): IBB, SBIO, AVDE, APIE, AVDS.

LKFT support price is $28.86 and resistance is $30.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LKFT shares will trade within this expected range on the day.